STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDCX
  4. [ARS] Medicus Pharma Ltd. SEC Filing

[ARS] Medicus Pharma Ltd. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
Rhea-AI Filing Summary
-
-
-
-
-
Positive
  • None.
Negative
  • None.
-
-
-
-
-
ARS - Medicus Pharma Ltd.

ARS Filing - Medicus Pharma Ltd.

This filing is available as a PDF document.

Filing Type: ARS

Company: Medicus Pharma Ltd. (MDCX)

Acceptance Date: 2025-06-30T17:01:04.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock MDCX logo
Medicus Pharma Ltd

NASDAQ:MDCX

MDCX Rankings

#7857 Ranked by Market Cap
N/A Ranked by Dividends

MDCX Latest News

Jun 30, 2025
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Jun 23, 2025
Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer
Jun 12, 2025
Medicus Pharma Ltd. to Present at 2025 Bio International Convention
Jun 9, 2025
Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses
Jun 2, 2025
Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

MDCX Latest SEC Filings

Jun 30, 2025
[DEF 14A] Medicus Pharma Ltd. Definitive Proxy Statement
Jun 30, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Jun 30, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Jun 30, 2025
[253G2] Medicus Pharma Ltd. SEC Filing
Jun 30, 2025
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)

MDCX Stock Data

43.50M
8.72M
Pharmaceutical Preparations
W. CONSHOHOCKEN